BioThrax (Emergent BioDefense Operations Lansing, LLC)
Welcome to the PulseAid listing for the BioThrax drug offered from Emergent BioDefense Operations Lansing, LLC. This Live Attenuated Bacillus Anthracis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Anthrax Vaccines [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Emergent BioDefense Operations Lansing, LLC |
| NON-PROPRIETARY NAME: | BACILLUS ANTHRACIS |
| SUBSTANCE NAME: | BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS |
| TYPE: | VACCINE |
| PHARMA CLASS: | Live Attenuated Bacillus Anthracis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Anthrax Vaccines [Chemical/Ingredient] |
| ROUTE: | INTRAMUSCULAR; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1970-11-04 |
| END MARKETING DATE: | 0000-00-00 |
BioThrax VACCINE Details:
| Item Description | BioThrax from Emergent BioDefense Operations Lansing, LLC |
| LABELER NAME: | Emergent BioDefense Operations Lansing, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(ug/mL) |
| START MARKETING DATE: | 1970-11-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64678-211_f5796150-9f9e-11e5-a837-0800200c9a66 |
| PRODUCT NDC: | 64678-211 |
| APPLICATION NUMBER: | BLA103821 |
Other BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS Pharmaceutical Manufacturers / Labelers:
